Thomas Ferkol, M.D. is a Professor of Pediatrics at the University of North Carolina at Chapel Hill. An American Lung Association Edward Livingston Trudeau Scholar, recipient of the Cystic Fibrosis Foundation Leroy Matthews Physician-Scientist Award and Primary Ciliary Dyskinesia Foundation Golden Cilium Award, his research has largely focused on the development of cell and animal models to study inherited, suppurative lung diseases, defining genetic and molecular factors that contribute to chronic airway infection, inflammation, and epithelial injury with almost 30-years of continuous funding from the National Institutes of Health (NIH). Dr. Ferkol has co-led the NIH-supported Genetic Disorders of Mucociliary Clearance Consortium, an established, multicenter collaborative that is defining the genetics, pathophysiology, and clinical features of primary ciliary dyskinesia. He has served on numerous international review groups and study sections, and written or co-authored over 200 original articles, scholarly reviews, and book chapters. Finally, Dr. Ferkol was President of the American Thoracic Society, only the second pediatrician to serve in this capacity during the 120-year history of the organization.
